Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125112684 | 12511268 | 4 | F | 20160517 | 20160928 | 20160629 | 20160928 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052641 | BRISTOL MYERS SQUIBB | 81.30 | YR | F | Y | 40.90000 | KG | 20160928 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125112684 | 12511268 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, BID | Y | 202155 | 2.5 | MG | FILM-COATED TABLET | BID | |||||
| 125112684 | 12511268 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 125112684 | 12511268 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125112684 | 12511268 | 1 | Product used for unknown indication |
| 125112684 | 12511268 | 2 | Product used for unknown indication |
| 125112684 | 12511268 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125112684 | 12511268 | HO |
| 125112684 | 12511268 | DE |
| 125112684 | 12511268 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125112684 | 12511268 | Atrial fibrillation | |
| 125112684 | 12511268 | Bone marrow failure | |
| 125112684 | 12511268 | Cerebral infarction | |
| 125112684 | 12511268 | Colitis ischaemic | |
| 125112684 | 12511268 | Melaena | |
| 125112684 | 12511268 | Platelet count decreased | |
| 125112684 | 12511268 | Renal disorder | |
| 125112684 | 12511268 | Respiratory failure | |
| 125112684 | 12511268 | Small cell lung cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125112684 | 12511268 | 1 | 20160613 | 0 | ||
| 125112684 | 12511268 | 2 | 20160608 | 0 | ||
| 125112684 | 12511268 | 3 | 20160608 | 0 |